The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis.
Lilong ZhangQihang YuanMan LiDongqi ChaiWenhong DengWei Xing WangPublished in: BMC cancer (2020)
The study shows that high leptin levels were associated with a higher risk of hepatocellular carcinoma. Adiponectin levels were proportional to hepatocellular carcinoma risk, and were related to the poor prognosis.